Biotricity changes year-end to move closer to qualifying to list on a National Exchange
Apr 25, 2017 12:03 pm UTC| Business
REDWOOD CITY, Calif., April 25, 2017 -- Biotricity, Inc.(OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has...
Biotricity changes year-end to move closer to qualifying to list on a National Exchange
Apr 25, 2017 12:03 pm UTC| Business
REDWOOD CITY, Calif., April 25, 2017 -- Biotricity, Inc.(OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has...
Summer Infant to Announce First Quarter 2017 Financial Results on May 4
Apr 25, 2017 12:02 pm UTC| Business
WOONSOCKET, R.I., April 25, 2017 -- Summer Infant, Inc. ("Summer Infant" or the "Company") (NASDAQ:SUMR), a global leader in premium juvenile products, today announced that it will host a conference call to discuss the...
Semtech's Award Winning UHD-SDI Gearbox Enables LYNX Technik’s greenMachine titan
Apr 25, 2017 12:02 pm UTC| Business
LAS VEGAS, April 25, 2017 -- Semtech Corporation (Nasdaq:SMTC), a leading supplier of analog and mixed-signal semiconductors, and LYNX Technik AG, a developer of equipment for broadcast and professional AV signal...
Summer Infant to Announce First Quarter 2017 Financial Results on May 4
Apr 25, 2017 12:02 pm UTC| Business
WOONSOCKET, R.I., April 25, 2017 -- Summer Infant, Inc. ("Summer Infant" or the "Company") (NASDAQ:SUMR), a global leader in premium juvenile products, today announced that it will host a conference call to discuss the...
Apr 25, 2017 12:02 pm UTC| Business
NORCROSS, Ga., April 25, 2017 -- Galectin Therapeutics, Inc.(NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis, skin diseases, and cancer, today announced that the...
Apr 25, 2017 12:02 pm UTC| Business
NORCROSS, Ga., April 25, 2017 -- Galectin Therapeutics, Inc.(NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis, skin diseases, and cancer, today announced that the...